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Background: Loss of endothelial cell integrity and selective permeability barrier is an early event in the sequence
of oxidant-mediated injury and may result in atherosclerosis, hypertension and facilitation of transendothelial
migration of cancer cells during metastasis. We already reported that endothelial cell integrity is tightly regulated
by the balanced co-activation of p38 and ERK pathways. In particular, we showed that phosphorylation of
tropomyosin-1 (tropomyosin alpha-1 chain = Tm1) at Ser283 by DAP kinase, downstream of the ERK pathway
might be a key event required to maintain the integrity and normal functions of the endothelium in response to
oxidative stress.
Methods: Endothelial permeability was assayed by monitoring the passage of Dextran-FITC through a tight
monolayer of HUVECs grown to confluence in Boyden chambers. Actin and Tm1 dynamics and distribution were
evaluated by immunofluorescence. We modulated the expression of Tm1 by siRNA and lentiviral-mediated
expression of wild type and mutated forms of Tm1 insensitive to the siRNA. Transendothelial migration of HT-29
colon cancer cells was monitored in Boyden chambers similarly as for permeability.
Results: We provide evidence indicating that Tm1 phosphorylation at Ser283 is essential to regulate endothelial
permeability under oxidative stress by modulating actin dynamics. Moreover, the transendothelial migration of
colon cancer cells is also regulated by the phosphorylation of Tm1 at Ser283.
Conclusion: Our finding strongly support the role for the phosphorylation of endothelial Tm1 at Ser283 to prevent
endothelial barrier dysfunction associated with oxidative stress injury.
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By gating the traffic of molecules and cells across the
vessel wall, vascular endothelial cells play an active role
in regulating cardiovascular and systemic homeostasis
and in modulating physiopathological processes such as
inflammation and immunity [1-3]. The functions of
endothelial cells are regulated by physiological agonists
and stress stimuli in a process called endothelial cell ac-
tivation. This process is associated with the induction of
intracellular signalling pathways that converge on the
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reproduction in any medium, provided the orthe synthesis and release of mediators of inflammation,
the induction of adhesion molecules, and with structural
changes in the actin cytoskeleton that govern motility
and permeability [4-6]. Dysfunction of the regulatory
systems of the endothelium and its incapacity to cope
with its physicochemical surrounding lead to disruption
of endothelial integrity and genesis of cardiovascular
pathologies including atherosclerosis, hypertension and
coagulation abnormalities [7,8].
Endothelial cells are heavily exposed to Reactive Oxy-
gen Species (ROS) and these latter are major regulators
of physiological and pathological processes involving the
endothelium. Notably, endothelial cells produce ROS in
response to ischemia-reoxygenation. In turn, ROS con-
tribute to the modulation of several signalling pathwaysral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ways regulating vascular permeability [9-12]. Import-
antly, loss of endothelial cell integrity and selective
permeability barrier is an early event in the sequence of
oxidant-mediated injury and may result in atheroscler-
osis, hypertension and facilitation of transendothelial mi-
gration of cancer cells (TEM) during metastasis [13-16].
It is thus of high clinical importance to better under-
stand how ROS regulate endothelial permeability in nor-
mal and pathological situations. Along these lines, the
current paradigm is that endothelial cell permeability is
regulated by the opposing centripetal-centrifugal forces
associated with cytoskeletal dynamics [17]. The equilib-
rium between the centripetal and centrifugal forces is
under the regulation of different signalling pathways.
Notably, we reported that endothelial cell integrity is
tightly regulated by the balanced co-activation of p38
and ERK pathways [18]. In particular, we showed that
in response to E-selectin activation, endothelial cell
permeability and TEM of cancer cells are regulated by
the formation of stress fibers by p38-dependent actin
polymerization and myosin light chain phosphorylation
and by ERK-dependent regulation of the VE-cadherin-
βcatenin complex at the adherens junctions [5]. In oxi-
dative stress conditions, the strong actin-polymerizing
activity generated through the p38/MAKAP kinase-2/
HSP27 axis is associated with membrane blebbing
when the ERK pathway is inhibited [19,20]. The bleb-
bing activity caused gaps in the endothelium layers,
which were due to an impairment of the phosphoryl-
ation of tropomyosin-1 (RecName: Full= Tropomyosin
alpha-1 chain, herein named Tm1) at Ser283 by DAP
kinase, downstream of the ERK pathway [19,21]. This
suggests that phosphorylation of tropomyosins might
be a key event required to regulate their functions.
Along these lines, phosphorylation of Tm1 at Ser283
is required for the formation of stress fibers and
thereby contraction of the endothelial cells [21]. On
the other hand, phosphorylation of TM2 at S61 occurs
downstream of the PI3K pathway and is required for
the internalization of the beta-adrenergic receptor [22].
Moreover, Tm1 kappa, a splice variant of Tm1α gene,
is increased in patients with chronic dilatated cardio-
myopathy and it modulates the sensitivity of the myo-
filaments in a phosphorylation-dependent manner [23].
The in vivo functions of Tms are not necessarily direct
and may require other actin binding proteins such as
caldesmon and HSP27 [24].
In the present study, we investigated the role of Tm1
in regulating endothelial cell permeability and TEM of
colon cancer cells in response to oxidative stress. We
show for the first time that phosphorylation of Tm1 at
Ser283 is a major regulator of both endothelial cell per-
meability and TEM in response to oxidative stress. Inparticular, we provide evidence indicating that phos-
phorylated Tm1 contributes to maintain the integrity of
the endothelium under oxidative stress condition by its
crucial participation to the remodelling of actin cytoskel-
eton into stress fibers. These finding strongly support
the role for the phosphorylation of Tm1 at Ser283 to




H2O2 and endothelial cell growth supplement (ECGS)
were from Sigma-Aldrich (Oakville, On, Canada).
PD098059 was purchased from Calbiochem (San Diego,
CA) and was diluted in DMSO to make stock solutions
of 20 mM. Histamine and NaF were purchased from
Sigma-Aldrich. Histamine was diluted in water to make
stock solutions of 5 mM. Chemicals for electrophoresis
were obtained from Bio-Rad (Mississauga, On, Canada)
and Fisher Scientific (Montréal, Qc, Canada).
Cells
HUVECs were isolated by collagenase digestion of umbil-
ical veins from undamaged sections of fresh cords [20].
The cords were obtained after approbation by the
CRCHUQ ethical committee. Subcultures were maintained
in EGM2 media (LONZA, Allendale, NJ, USA). Replicated
cultures were obtained by trypsinization and were used at
passages <5. Human Embryonic Kidney cells (HEK293T)
were cultivated in DMEM containing 10% foetal bovine
serum (FBS) and antibiotics. Human colorectal adenocarcin-
oma cells (HT29) were cultivated in McCoy’s 5A medium
supplemented with 10% FBS. Cultures were maintained at
37°C in a humidified atmosphere containing 5% CO2.
Antibodies
Anti-tropomyosin (clone TM311) monoclonal and anti-
α-tubulin mouse monoclonal (clone B-512) antibodies
were purchased from Sigma. Anti-living color (GFP)
rabbit polyclonal antibody was purchased from BD Bios-
ciences (Mississauga, On, Canada). Anti-mouse-IgG-
horseradish peroxidase (HRP) and anti-rabbit-IgG-HRP
antibodies were from Jackson Laboratory (Bar Harbor,
ME, USA). Anti-ERK2 is a rabbit polyclonal antibody
raised against a synthetic peptide that corresponds to
the 14 C-terminal amino acids of rat ERK2 [20].
Plasmids and small interfering RNA (siRNA)
Tropomyosin-1 cDNA (RecName :Full= Tropomyosin
alpha-1 chain, herein named Tm1) was cloned by PCR
amplification from IMAGE clone 562592 (ATCC) into
pIRES-hrGFP2a [21]. The tropomyosin-1 S283A was
generated by PCR site-directed mutagenesis on pIRES-
hrGFP2a-tropomyosin-1 construct using the primers 50-
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and 50-TTATATAGCAGTCATATCGTTGAGAGCGTGG-
30 [21]. Validated Tm1 siRNA #7 (Hs_TPM1_7) was pur-
chased from QIAGEN (Mississauga, On, Canada) and
was designed to target the mRNA of human Tm1
(GenBankTM accession no. NM_ 000366.1). The target
sequence of Tm1 siRNA #7 is as follows: sense, 50-GAGUG
AGAGAGGCAUGAAATT-30 and antisense, 50-UUUCA
UGCCUCUCUCACUCTC-30. Non-targeting silencer nega-
tive control siRNA #1 was purchased from Ambion (Austin,
TX, USA). The tropomyosin-1 wild-type (Tm1wt) and
tropomyosin-1 S283A (Tm1S283A) constructs were ren-
dered insensitive to Tm1 siRNA #7 by PCR-mediated muta-
genesis at the sites indicated in bold in the mutagenic
oligonucleotides: 50-GAGCGAGCGAGGGATGAAGGTCA
TTGAG-30 (sense) and 30-GTCTACTCTCGCTCGCTC
CCTACTTCC-50 (reverse). Plasmids necessary for lentiviral
particles production were a kind gift of Dr. Manuel Caruso
(Laval University, Qc, Canada). CSII-EF-MCS-IRES2-Venus
(CSII-Venus) vector was a kind gift of Dr. Hiroyuki Miyoshi
(RIKEN Tsukuba Institute, Japan). Tm1S283A insensitive to
siRNA #7 was subcloned in CSII-Venus vector using NotI
and BamHI restriction sites (CSII-Venus-Tm1S283A). The
CSII-Venus-Tm1wt construct insensitive to siRNA #7 was
generated by PCR site-directed mutagenesis on CSII-Venus-
Tm1S283A construct using the following primers:
sense, 50-TATGACTTCCATATAAGGATCCGCCCC
TCTCCCTCCCCC-30 and antisense, 50-GCGGATCCT
TATATGGAAGTCATATCGTTGAGAGCGTGGTCCA
G-30. KOD Hot Start DNA polymerase was used accord-
ing to the manufacturer protocol (EMD, Philadelphia,
PA, USA).Lentiviral particle preparation
HEK293T were plated at 3×106 per 100 mm Petri dish
in 10 ml DMEM supplemented with 10% FBS. Co-
transfection was performed by Ca2+ phosphate-mediated
transfection using 2.5 μg of pRSV-Rev, 6.5 μg of
pMDLg-pRRE, 3.5 μg of pMD2.G together with 10 μg of
transgene expressing vectors (CSII-Venus, CSII-Venus-
Tm1wt or CSII-Venus-Tm1S283A). After overnight incu-
bation, media were replaced with 5 ml lentiviral particle
collection media (M199 medium containing 20% heat-
inactivated FBS, ECGS, L-glutamine, heparin and anti-
biotics). After 24 hours, the media were collected and
centrifuged at 1200 g, for 5 minutes at 4°C. The super-
natant was stored in aliquots at −80°C. The Multiplicity of
Infection (MOI), known as the ratio of infectious virus
particles per cell, was determined after a 48 hours trans-
duction of HUVECs in cascade dilution experiment. The
percentage of GFP positive cells was determined by FACS
using EPICS-XL-MCL flow cytometer (Beckman-Coulter,
Ramsey, MN, USA) [25,26].Transfection and transduction
HUVECs and HEK293T were transfected with siRNA or
plasmid vectors using X-tremeGene HP Transfection Re-
agent obtained from Roche (Laval, Qc, Canada) according
to the manufacturer’s protocol or by electroporation [21].
HUVECs were transduced or not with CSII-Venus (empty
vector) or CSII-Venus-Tm1wt (Tm1 wild-type vector) or
CSII-Venus-Tm1S283A (non-phosphorylatable Tm1
mutant vector) using lentivirus-mediated infection in the
presence of 8 μg/ml hexadimethrine bromide (Sigma-
Aldrich, Oakville, On, Canada).Western blotting
After treatment, cells were lysed using SDS-PAGE load-
ing buffer. Equal amounts per well of total proteins were
separated by SDS-PAGE, and the gels were transferred
onto nitrocellulose membranes for western blotting.
After incubating nitrocellulose membranes with the ap-
propriate primary antibodies, antigen-antibody com-
plexes were detected with an anti-IgG antibody coupled
to horseradish peroxidase and then revealed using an
enhanced chemiluminescence kit. Quantification of
immunoreactive bands was done by densitometric scan-
ning using the Image J software.
Endothelial permeability assay
Permeability across endothelial cell monolayers was mea-
sured using gelatin-coated Transwell units (Boyden
chambers) [6.5 mm diameter, 0.4 μm pore size polycarbon-
ate filter; Corning Costar; Pittston, PA, USA]. Transfection
and transduction--First day, HUVECs were plated at a
density of 3×105 cells per 60 mm Petri dishes and were cul-
tured for 24 hours. Second day, exponentially growing
HUVECs were transduced or not with CSII-Venus (empty
vector) or CSII-Venus-Tm1wt (Tm1 wild-type vector) or
CSII-Venus-Tm1S283A (non-phosphorylatable Tm1 mu-
tant vector) using lentivirus-mediated infection in the
presence of 8 μg/ml hexadimethrine bromide. After
24 hours, infected or non-infected HUVECs were trans-
fected or not (controls) with Tm1 siRNA #7 using X-
tremeGene HP Transfection Reagent according to the
manufacturer’s protocol. The next day, HUVECs were
plated at a density of 0.6×105 cells (or 1×105 in the case
of transduced cells) per well (upper chamber) and were
cultured for 3 days until the formation of a tight mono-
layer. Endothelial permeability was determined by mea-
suring the passage of FITC-labelled dextran (1 mg/ml of
fluorescein isothiocyanate-dextran, molecular mass: 40 kDa;
Sigma-Aldrich) through the HUVEC monolayer. Thereafter,
NaF (1 mM for 1 hour) was added to the incubation
medium (upper chamber) to inhibit phosphatases and allow
the accumulation of phosphorylated tropomyosin-1. Then,
H2O2 was added to the upper chamber in the presence of
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ment, 100 μl was collected from the lower compartment
and fluorescence was evaluated using a Fluoroskan Ascent
Microplate Fluorometer following manufacturer’s protocol
(Thermo Scientific, Mtl, Qc, Canada).Transendothelial cell migration assay
Cancer cell migration through endothelial barrier in re-
sponse to H2O2 was studied in Boyden chambers (6.5 mm
diameter, 5.0 μm pore size polycarbonate filter; Corning
Costar; Pittston, PA, USA). HUVECs transduced and
transfected as mentioned above (see section Endothelial
permeability assay) were plated at a density of 1.0×105 per
well and were cultivated for 3 days until the formation of
a tight monolayer. Thereafter, H2O2 was added to the
upper chamber for 30 minutes. Then, EGM2 medium was
removed and replaced by migration buffer (199 medium,
10 mM HEPES pH 7.4, 1 mM MgCl2, and 0.5% bovine
serum albumin). HT-29 were harvested with trypsin,
counted, centrifuged, and resuspended at 1×106 cells/ml
in McCoy’s medium (McCoy’s 5A medium supplemented
with 10% FBS). Then, HT-29 were stained with calcein
(500nM) for 30 minutes at 37°C, were centrifuged, and
were resuspended at 1.5×106 cells/ml in migration buffer.
Cancer cells were added on the HUVEC monolayer at a
density of 1.5×105 cells per well. After 4 hours and a half
of migration, cells in the upper chamber were removed
with a cotton swab. Then, HT-29 cells that crossed the
membrane of the Boyden chamber were counted in five
different fields using a Nikon TE300 fluorescence micro-
scope equipped with a 20x objective.Cell viability assay
Cell viability has been determined by using the Quick
Cell Proliferation Assay Kit from BioVision. This cell
proliferation and viability assay is based on the enzym-
atic cleavage of the tetrazolium salt WST-1 to formazan
dye by cellular mitochondrial dehydrogenases that are
active in viable cells only. The formazan dye produced
by viable cells is quantified by measuring the absorb-
ance of the dye solution at 440 nm. The exact proced-
ure that was followed was as described in the BioVision
protocol sheet.Fluorescence microscopy
Confocal microscopy was used for immunofluorescence
visualization of F-actin, tropomyosin-1 and EGFP.
HUVECs were plated on gelatin-coated microscope cover
slides into 35 mm Petri dishes. After treatment, cells were
fixed with 3.7% formaldehyde and permeabilized with
0.1% saponin in phosphate buffer, pH 7.5. F-actin was
detected using Alexa-488-phalloidin (Invitrogen, Carlsbad,CA) diluted 1:400 in phosphate buffer. Tropomyosin-1
was detected using an anti-tropomyosin (clone TM311)
mouse monoclonal antibody. Living color rabbit antibody
was used for EGFP staining. The antigen-antibody com-
plexes were detected with Alexa-568-mouse-IgG or
Alexa-568-rabbit-IgG secondary antibodies. The cells were
examined using Nikon Eclipse 600 microscope equipped
with 20x and 40x objectives.Statistical analysis
Results are expressed as mean values ± SEM. Unless spe-
cified, the figures present results that were obtained from
a representative experiment of at least three distinct
experiments. The n value means the total number of repli-
cates in this experiment. Unpaired Student t test was used
for comparison between two means. A p-value <0.05 was
considered as statistically significant.
Results
H2O2 induces the formation of transcytoplasmic stress
fibers and increases endothelial cell permeability
In response to oxidative stress, activation of the p38
pathway favours actin polymerization, which contributes
to cytoskeletal remodelling into stress fibers, which in
turn, are required to regulate endothelial permeability
[17,20]. Accordingly, inhibition of ROS-induced p38 ac-
tivation dampens the increase in endothelial cell perme-
ability [27]. Intriguingly, in the presence of ERK
inhibition, the strong actin polymerization generated via
the p38 pathway induced by ROS is associated with
membrane blebbing, an early toxic manifestation of oxi-
dative stress [18,28]. We provided evidence indicating
that ROS-induced membrane blebbing resulted in an in-
hibition of ERK-dependent phosphorylation of Tm1
downstream of Death Associated-Protein Kinase-1
(DAPK1) [18,20,21,28]. This suggested that activation of
the ERK-Tm1 axis might be a key determinant in main-
taining the integrity of the endothelium in response to
oxidative stress. In this context, we investigated herein
the role of the ERK-Tm1 axis in regulating endothelial
cell permeability in response to ROS.
We first ascertained whether oxidative stress induced
an increase in endothelial cell permeability. HUVEC cul-
tivated as tight monolayers in Boyden chambers were
treated or not with 250 μM H2O2 for 30, 60 and 90 min-
utes. Thereafter, permeability was determined by meas-
uring the passage of FITC-labelled dextran (molecular
mass: 40 kDa) across endothelial cell monolayers.
Results showed that H2O2 as well as histamine, taken as
a positive control, increased endothelial permeability in
a time-dependent manner (Figure 1A). In both cases,
ROS- and histamine-induced increase in endothelial cell
permeability was associated with formation of actin
Figure 1 Oxidative stress induces actin remodelling, disruption of endothelial layer integrity and increase of endothelial permeability.
A) HUVECs were plated in the upper part of a Boyden chamber at a density of 0.6×105 per well and were cultivated for 3 days until the
formation of a tight monolayer. Then, FITC-labelled dextran was added (1 mg/ml) together or not with H2O2 (250 μM) or histamine (10 μM) for
the indicated periods of time. The data represent the permeability changes obtained in a representative experiment and are expressed as the
mean fold increase (± SEM) in treated cells relative to untreated cells (n=4 for each conditions). p value was determined by using unpaired
Student t test. B) Exponentially growing HUVECs were left untreated (a) or were treated with H2O2 (250 μM; b) or histamine (10 μM; c) for
30 minutes. Cells were then fixed, were permeabilized, and were stained for F-actin using Alexa 488-phalloidin. A representative field is shown for
each condition. Pictures were captured using a Nikon Eclipse 600 fluorescence microscope (40X).
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by these structures in regulating endothelial cell integrity
(Figure 1B). Interestingly, the cytoskeletal remodelling
induced by H2O2 and histamine was accompanied by an
increase in the width of interendothelial spaces, which
reflects cellular contraction that favours permeability to
Dextran (Figure 1B). However, the 30 min treatment
with 250 μM H2O2 did not influence cell viability as
measured by the cleavage of WST-1 tetrazolium salt in
formazan by mitochondrial dehydrogenase activity of vi-
able cells (Additional file 1: Figure S1).
Next, we evaluated the role of the ERK pathway in
maintaining endothelial integrity in response to H2O2.
First, we found that H2O2 enhanced by 4-fold the activa-
tion of ERK after 30 min (Figure 2A). Then, we set up
an endothelial permeability assay in which we inhibited
the ERK pathway at the level of MEK1/2 using
PD098059 [29] (Figure 2A). Results showed that the
H2O2-induced endothelial cell permeability was still fur-
ther increased by 1.4-fold at 30 min when ERK was
inhibited. Indeed, the increased endothelial cell perme-
ability when the ERK pathway was inhibited was augmen-
ted by 1.8-fold in comparison to 1.3-fold when the ERK
pathway was functional (Figure 2B). Interestingly,
PD098059 did not affect by itself endothelial cellpermeability for exposure times up to 90 min (Additional
file 1: Figure S2).
These findings are strong evidence in support that the
ERK pathway is a major regulator of endothelial perme-
ability and that its deregulation in the presence of ROS
is associated with disruption of the endothelial barrier
functions.
Tropomyosin-1 regulates endothelial barrier integrity in
response to oxidative stress
We previously reported that ROS-induced phosphoryl-
ation of Tm1 at Ser283 by DAP Kinase-1, downstream
of ERK, is required to secure the formation of stress
fibers and protects endothelial cell against early mem-
brane blebbing [19,21]. Based on these findings, we
decided to investigate next the involvement of Tm1 in
maintaining the endothelial barrier integrity in response
to oxidative stress. To this end, we proceeded to experi-
ments in which we knocked down the expression of en-
dogenous Tm1 by means of siRNAs (Figure 3A and
Additional file 1: Figure S3). HUVECs were co-
transfected for 72 hours with siRNA7Tm1 or with a
non-targeting siRNA (Silencer, Negative Control #1).
Monolayers of endothelial cells were treated with
250 μM H2O2 for 30 minutes and permeability was
Figure 2 Inhibition of the ERK MAP kinase in the presence of
H2O2 is associated with an increase of endothelial permeability.
A) Exponentially growing HUVECs were pretreated with vehicle
(0.25% DMSO) or with PD098059 (50 μM) for 60 minutes. Thereafter,
HUVECs were treated or not with H2O2 (250 μM) for 30 minutes.
Proteins were extracted, were separated by SDS-PAGE, and were
transferred onto nitrocellulose membrane. Inhibition of the ERK
pathway was revealed by western blot using phospho-ERK specific
antibody (upper panel). Total ERK (ERK2) and tubulin-α expression
levels were determined as loading controls (middle and lower
panels, respectively). A representative blot is shown B) HUVECs were
plated at a density of 0.6×105 per well in the upper part of a
Boyden chamber and were cultivated for 3 days until the formation
of a tight monolayer. Then, the monolayers were pretreated with
vehicle (0.25% DMSO) or with PD098059 (50 μM) for 60 minutes,
and then they were treated or not with H2O2 (250 μM) for
30 minutes. Passage of FITC-labelled dextran through the monolayer
of HUVECs was measured immediately after treatment. The results
represent the permeability changes obtained in a representative
experiment and are expressed as the mean fold increases (± SEM) in
treated cells relative to untreated cells (n=3). p value was
determined by using unpaired Student t test.
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Additional file 1: Figure S3, siRNA7Tm1 almost com-
pletely inhibited (by 80%) the expression of Tm1, as
determined by densitometric analysis of the western
blots performed on cell samples extracted just before the
permeability assays. This siRNA-mediated knockdown of
Tm1 was associated with an ~2.0-fold increase in
endothelial permeability to H2O2 (Figure 3B). In con-
trast, the endothelial permeability to FITC-labelled
dextran was only ~1.4-fold in H2O2-treated HUVEC
monolayers expressing non-targeting siRNA. Of note,
the knockdown of Tm1 by itself was associated with a~1.4-fold increase in endothelial cell permeability,
which is associated with a decreased formation of
stress fibers (Figure 3C, Panel j-l). In both cases, this
is in line with the fact that Tm1 is an essential com-
ponent of the endothelial cell integrity. Consistent with
the role of Tm1 in stress fiber formation and with the
contribution of these latter in maintaining the integrity
of the barrier, we found that the knockdown of Tm1
was associated with a loss of stress fibers and with
interendothelial spaces when the cells were treated
with 250 μM H2O2 for 30 minutes (Figure 3C: see notably
panels j-l vs m-o).
Together, these results constitute the first proof
indicating that endogenous human Tm1 is required to
maintain the integrity of the endothelial layer in re-
sponse to ROS.
Phosphorylation of Tm1 at Ser283 regulates endothelial
permeability
The inhibition of the ERK pathway is associated with a
decrease in Tm1 phosphorylation at Ser283, which is ac-
companied by the disappearance of the H2O2-mediated
formation of stress fibers [19,21]. These effects result in
breaking the delicate equilibrium between the balanced
activation of the ERK and p38 pathways required for the
formation of stress fibers and for the normal functioning
of endothelial cells in the presence of ROS [18]. In
addition, they suggest that phosphorylation of Tm1 at
Ser283 downstream of ERK is important to regulate the
selective endothelial permeability under oxidative stress.
Accordingly, we next verified whether phosphorylated
Tm1 at Ser283 plays a role in permeability regulation in
response to H2O2. To this purpose, we used an approach
based on knocking down endogenous Tm1 with siRNA
Figure 3 The knockdown of human Tm1 induces an increase in endothelial permeability in response to H2O2. A) HUVECs were
electroporated or not with Hs_TPM1_7 siRNA (siRNA7Tm1) or non-targeting silencer negative control siRNA. Three days later, proteins were
extracted, were separated by SDS-PAGE, and were transferred onto nitrocellulose membrane. Tm1 level was revealed by western blot using anti-
tropomyosin mouse monoclonal antibody (upper panel). Tubulin-α level was measured as loading control (lower panel). The siRNA7Tm1-
mediated knockdown of Tm1 has been evaluated as 80% following densitometric quantification of the bands. A representative blot is shown.
B) HUVECs transfected as in A using X-tremeGene HP Transfection Reagent were plated at a density of 0.6×105 per well in the upper part of a
Boyden chamber and were grown for 3 days until the formation of a tight monolayer. Passage of FITC-labelled dextran through the monolayer of
HUVECs was measured after exposure to H2O2 (250 μM) for 30 minutes. The data represent permeability expressed as the mean fold increases in
treated cells (± SEM) relative to untreated cells (n=3 for each conditions). p value was determined by using unpaired Student t test C) HUVECs
were transfected or not (a-c) with siRNAs that specifically target human Tm1 mRNA (j-o) or with non-targeting negative control siRNA (d-i). The
next day, HUVECs were plated at a density of 2×105 cells on gelatin-coated microscope cover glasses into 35 mm Petri dish for each condition
and were grown for 2 days until the formation of a tight monolayer. Thereafter, cells were treated or not with H2O2 (250 μM) for 30 minutes (g-i
and m-o). Then, cells were fixed, were permeabilized, and were stained for F-actin using Alexa 488-phalloidin (a, d, g, j and m), and for Tm1 using
anti-tropomyosin mouse monoclonal antibody (b, e, h, k and n). A merged picture is shown for each condition (c, f, i, l and o). A representative
field for each condition was captured using a Nikon Eclipse 600 fluorescence microscope (40X).
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Figure 4 Phosphorylation of Tm1 at Ser283 regulates endothelial permeability. Exponentially growing HUVECs were transduced or not
with CSII-Venus (empty vector; MOI of 30.2) or CSII-Venus-Tm1wt (Tm1 wild-type vector; MOI of 7.59) or CSII-Venus-Tm1S283A (non-
phosphorylatable Tm1 mutant vector; MOI of 6.66) using lentivirus-mediated infection. These Tm1 constructs are insensitive to siRNA7Tm1. After
24 hours, infected HUVECs were transfected with siRNA7Tm1. In A) HUVECs were plated at a density of 1x105 cells per well in the upper part of a
Boyden chamber and were cultivated for 3 days until the formation of a tight monolayer. Thereafter, NaF (1 mM for 1 hour) was added to the
incubation medium (upper chamber) to inhibit phosphatases and to allow the accumulation of phosphorylated tropomyosin-1. Then, H2O2
(250 μM for 30 or 60 minutes) was added to the upper chamber in the presence of 1 mg/ml FITC-labelled dextran. Passage of FITC-labelled
dextran through the monolayer of HUVECs was measured immediately after exposure of HUVECs to H2O2. The data represent permeability
expressed as the mean fold increase (± SEM) relative to untreated cells (n=4 for each condition obtained from a representative experiment out of
4). p value was determined by using unpaired Student t test. In B) HUVECs were plated at a density of 2×105 cells on gelatin-coated microscope
cover glasses into 35 mm Petri dish per condition and were cultivated for 2 days until the formation of a tight monolayer. Thereafter, cells were
treated with H2O2 (250 μM) for 30 minutes (d-f, j-l and p-r) or were left untreated (a-c, g-i and m-o). Then, cells were fixed, were permeabilized,
and were stained for F-actin using Alexa 488-phalloidin (a, d, g, j, m and p), and for Tm1 using anti-tropomyosin monoclonal mouse antibody(b,
e, h, k, n and q). A merged picture is shown for each condition (c, f, i, l, o, and r). A representative field for each condition was captured using a
Nikon Eclipse 600 fluorescence microscope (40X).
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the knockdown. Briefly, we first introduced, via
lentiviral-mediated infection, a wt form or a Ser283Ala
mutated form of Tm1 that are insensitive to siR-
NA7Tm1 (Additional file 1: Figure S4). Twenty-four
hours later, the cells were transfected for another
24 hours with siRNA7Tm1 to knock down endogenous
Tm1. Then, endothelial cells were cultivated as mono-
layers in Boyden chambers, and permeability in the pres-
ence or not of 250 μM H2O2 for 30 and 60 min was
assayed as above. As shown in Figure 4A, we found a
significant 26% (30 min) and 22% (60 min) increase in
endothelial permeability in HUVEC monolayers trans-
duced with CSII-Venus-Tm1S283A. In contrast, there
were strong 86% (30 min) and 85% (60 min) decreases of
endothelial permeability in HUVEC monolayers trans-
duced with CSII-Venus-Tm1wt. Moreover, consistent with
the key role played by phosphorylation of Tm1 at Ser283
for the formation of stress fibers and with the role of these
latter in permeability, we found that the introduction of
wt form of Tm1 is associated with an increase formation
of stress fibers in response to H2O2 (Figure 4B: panels j-l).
In contrast, the introduction of the mutated Tm1S283A is
associated with absence of stress fibers (Figure 4B: panels
m-o), with interendothelial gaps and thereby increased
endothelial permeability to H2O2 (Figure 4B: panels p-r).
Interestingly, our results revealed that lentivirus-mediated
infection did not increase by itself endothelial permeability
and did not affect cell viability (Additional file 1: Figure S5
and Additional file 1: Figure S6).
Altogether, these results indicate for the first time that
phosphorylation of Tm1 at Ser283 is essential to main-
tain the normal regulation of endothelial permeability in
response to oxidative stress.
Phosphorylation of Tm1 at Ser283 regulates
transendothelial migration of HT-29 colon cancer cells
Transendothelial migration (TEM) of circulating cancer
cells is a key determinant of the metastatic process [16].Along these lines, TEM and metastasis are both import-
antly dependent on the integrity of the endothelium and
are both affected by ROS [30]. As we reported above,
phosphorylation of Tm1 at Ser283 is a major mechanism
that confers protection against ROS-induced damage to
the endothelial layer. Hence, we next investigated
whether phosphorylation of Tm1 at Ser283 regulates
TEM under oxidative stress. To ascertain the role of
Tm1 in regulating transendothelial permeability under
oxidative stress conditions, we first knocked down the
expression of endogenous Tm1 via siRNA. Thereafter,
cells were cultivated as tight monolayers on a 5.0 μm
pore size gelatinized polycarbonate membranes separat-
ing the two parts of a 6.5 mm Boyden chambers. The
cells were then treated or not with H2O2 (250 μM) for
30 min. H2O2-containing media were then removed and
were replaced by fresh media containing calcein labeled
HT-29 cells in suspension. After 4 hours and a half, the
number of HT-29 cells that have crossed the endothelial
layer was counted. Consistent with the role of Tm1 in
regulating endothelial permeability, we found that trans-
endothelial migration of HT-29 cells was increased by
~2-fold when HT-29 cells were added to a layer of
HUVEC in which Tm1 has been knocked down
(Figure 5).
Given that the Tm1-mediated effect on endothelial in-
tegrity depends on its phosphorylation at Ser283, we
next verified the role of Tm1 phosphorylation on TEM.
The approach used was analogous to that used to inves-
tigate the role of Tm1 phosphorylation in regulating
endothelial permeability. Briefly, a wild type form or a
Ser283Ala mutated form of Tm1 that are insensitive to
siRNA7Tm1 were first introduced in the cells, via
lentiviral-mediated infection, (Additional file 1: Figure S4).
Twenty-four hours later, the cells were transfected for an-
other 24 hours with siRNA7Tm1 to knock down en-
dogenous Tm1. Endothelial cells were then cultivated as
monolayers in Boyden chambers and then were treated in
the presence or not of H2O2 (250 μM) for 30 min. Then,
Figure 5 The knockdown of human Tm1 in endothelial cells is associated with an increase of transendothelial migration of cancer
cells. Exponentially growing HUVECs were transfected or not with siRNA7Tm1 or with non-targeting negative control siRNA. The day after,
HUVECs were plated at a density of 0.6×105 per well in the upper part of a Boyden chamber and were cultivated for 3 days until the formation of
a tight monolayer. Thereafter, H2O2 (250 μM) was added or not to the upper chamber for 30 minutes. Then, the medium was removed and
replaced by migration buffer. HT-29 cells previously stained with calcein were added on the upper chamber at a density of 1.5×105 cells per well.
After 4 hours and a half, HT-29 cells that crossed the membrane of the Boyden chamber were counted in five different fields using a TE300 Nikon
fluorescence microscope (20X). In each condition, the number of HT-29 trans-migrating cells was calculated from triplicate samples of a
representative experiment (mean±SEM). p value was determined by using unpaired Student t test.
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taining HT-29 cells labelled with calcein. After 4 hours
and a half, the number of cells that have crossed the layer
was counted. The results showed that the re-introduction
of the wt form of Tm1 rescued the increased transen-
dothelial permeability in untreated condition as well as in
the presence of H2O2. In contrast, TEM of HT-29 cells
was markedly increased in cells expressing Tm1 Ser283-
Ala. This increase was observed either in endothelial cells
that have been treated or not with H2O2. Yet the effect
was more pronounced in this latter case (Figure 6).
Overall, these results are consistent with the hypoth-
esis that increased endothelial permeability is a permis-
sive event for transendothelial migration of cancer cells
and that phosphorylation of Tm1 at Ser283 is import-
antly involved in regulating these events.Discussion
It is now accepted that circulating ROS can cause endo-
thelial barrier dysfunction, which may lead to several path-
ologies, notably atherosclerosis. However, the molecular
mechanisms involved are still poorly understood. We pre-
viously suggested that the phosphorylation of Tm1 could
contribute to maintain endothelial integrity during oxida-
tive stress. In the present study, we now firmly demon-
strate the crucial importance of the Tm1 phosphorylation
in the regulation of endothelial permeability and transen-
dothelial migration of cancer cells (TEM).The major finding of our study is that we show that
Tm1 expression is important to maintain the endothelial
barrier integrity in response to oxidative stress. Two
experiments support these new findings. First, perme-
ability assays confirm that the knockdown of Tm1 by
small RNA interference in HUVEC monolayers is tightly
associated with a heavy increase of endothelial perme-
ability and TEM of cancer cells in response to oxidative
stress. Second, in immunofluorescence assays, HUVEC
in which Tm1 was decreased with siRNA7Tm1 under
oxidative stress conditions display a marked disappear-
ance of stress fibers, a high level of inter endothelial gaps
and membrane blebbing.
Another major accomplishment of the present study is
to show that Tm1 phosphorylation at Ser283, down-
stream of ERK is a crucial mechanism that contributes
to maintain the selective transendothelial permeability in
response to oxidative stress. This finding is supported by
two principal observations. First, HUVEC monolayer
expressing human non-phosphorylatable Ser283Ala Tm1
insensitive to siRNA7Tm1 and in which human en-
dogenous Tm1 is knocked-down, are characterized by a
strong increase of transendothelial permeability under
oxidative stress conditions. In contrast, the ectopic ex-
pression of human wild-type Tm1 is rather accompanied
by an acute decrease of transendothelial permeability in
response to oxidative stress. Second, when the expres-
sion of human endogenous Tm1 is knocked-down in
cells expressing an exogenous nonphosphorylatable
Figure 6 Phosphorylation of Tm1 at Ser283 is associated with a decrease of cancer cells migration through the endothelial barrier
in response to H2O2. Exponentially growing HUVECs were transduced with CSII-Venus (empty vector; MOI of 30.8) or CSII-Venus-Tm1wt (Tm1
wild-type vector; MOI of 10.4) or CSII-Venus-Tm1S283A (non-phosphorylatable Tm1 mutant vector; MOI of 9.9) using lentivirus-mediated infection.
These Tm1 constructs were insensitive to siRNA7Tm1 that was transfected 24 hours later in each condition. The next day, HUVECs were plated at
a density of 1.0x105 per well in the upper part of a Boyden chamber and were cultivated for 3 days until the formation of a tight monolayer.
Thereafter, H2O2 (250 μM) was added or not to the upper chamber for 30 minutes. Then, the medium was removed and replaced by migration
buffer. HT-29 cells previously stained with calcein were added on the upper chamber at a density of 1.5×105 cells per well. After 4 hours and a
half, HT-29 cells that crossed the membrane of the Boyden chamber were counted in five different fields using a TE300 Nikon fluorescence
microscope (20X). In each condition, the number of HT-29 trans-migrating cells was calculated from triplicate samples of a representative
experiment (mean±SEM). p value was determined by using unpaired Student t test.
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thelium shows important toxic features such as strong
shrinkage, high level of inter-endothelial gaps, presence
of membrane blebbing, and a total absence of stress
fibers. In contrast, the over-expression of human ex-
ogenous wild-type Tm1 in similar condition plays a pro-
tective role on the endothelial barrier exposed to
oxidative stress.
It has been proposed that actin polymerization and re-
modelling are important regulators of the endothelial
permeability barrier [18,31]. Along these lines, our
results reveal a strong reorganization of F-actin into
transcytoplasmic stress fibers in HUVEC monolayers
treated with H2O2. Almost all cells were elongated with
thick actin stress fibers, which traversed the cells in the
direction of cell elongation. Moreover, we distinguished
an acute presence of inter endothelial gaps suggesting an
H2O2-mediated retraction of the cells. We also noticed
the same typical morphological pattern with histamine
treatment, a potent inducer of endothelial and vascular
permeability [32]. Based on these findings, the H2O2 and
histamine-mediated changes in the organization of actin
seem to be a fast and strong response that contributes to
increase stress resistance. In this context, the actin depo-
lymerising toxin cytochalasin D decreases endothelial
barrier function [33,34]. Hence by its participation tothe formation and stabilization of stress fibers, the phos-
phorylation of Tm1 may regulate the actin-based con-
traction/retraction of endothelial cells that controls the
permeability of the endothelium. Along these lines, other
proteins known to modulate actin dynamics and stress
fiber formation, such as the small GTPase RhoA, are
also known to regulate endothelial cell permeability and
TEM [35-37].
The tightness of the vessel walls represents a func-
tional barrier that contributes to limit cancer cell TEM
and ultimately metastasis. In that regard, dysfunction of
the endothelial integrity is associated with metastasis
[16,38,39]. Notably, certain breast, bladder, and kidney
cancer cells induce alterations of endothelial mechanical
properties to ease their TEM [40]. Given the determin-
ant role played by Tm1 phosphorylation at Ser283 in
maintaining the integrity of endothelial cell in response
to oxidative stress, one could expect that this mechan-
ism may also protect against metastasis. This is, indeed,
supported for the first time by our results. First, in re-
sponse to H2O2, TEM of colon cancer HT-29 cells
through HUVEC monolayers in which endogenous Tm1
expression is knocked-down by siRNA7Tm1 shows a
higher number of transmigrating cells than through con-
trol HUVEC monolayer expressing endogenous Tm1. Sec-
ond, the ectopic expression of human nonphosphorylatable
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monolayer in which expression of human endogenous Tm1
is knocked-down is associated with an increased level of
transendothelial migrating HT-29 cells in response to
H2O2. In contrast, the expression of human exogenous
wild-type Tm1 in similar conditions is associated with an
acute decreased level of transendothelial migrating HT-29
cells. These results strengthen the point that phosphoryl-
ation of Tm1 at Ser283 is crucial to restrict the transen-
dothelial migration of cancer cells under oxidative stress
conditions.
In conclusion, we propose that Tm1 is required to
maintain the endothelial barrier integrity against mole-
cules as well as against cancer cells both under unstimu-
lated as well as under oxidative stress conditions. We
also propose that the phosphorylation of Tm1 on
Ser283, downstream of ERK, is a key event for the regu-
lation of endothelial permeability by modulating the
contraction/retraction of the endothelial cells via remod-
elling of the actin cytoskeleton dynamics. These finding
strongly support the role for the phosphorylation of
Tm1 at Ser283 to prevent endothelial barrier dysfunc-
tion associated with oxidative stress.Additional file
Additional file 1: Figure S1. Endothelial cell survival is not decreased
by 250 μM H2O2. HUVECs were cultivated to confluence in a 96-well
plates. They were left untreated or were treated for 30 min with 250 μM
H2O2. Medium containing H2O2 was removed and fresh medium was
added. Then, cells were processed for WST-1 assay. Thereafter,
absorbance of the samples was determined at 420-480 nm to evaluate
the mitochondrial dehydrogenase activity of viable cells as measured by
the formation of formazan dye from WST-1. Results are expressed as the
mean DO values (+/−SEM) of viable cells from triplicates samples in each
condition and are from a representative experiment. p value was
determined by using unpaired Student t test. Figure S2. The MEK1
inhibitor PD098059 does not affect endothelial cell permeability. HUVECs
were plated in the upper part of a Boyden chamber at a density of
0.6×105 per well and were cultivated for 3 days until the formation of a
tight monolayer. Then, FITC-labelled dextran was added (1 mg/ml)
together with DMSO (0.25%) alone or with PD098059 for the indicated
period of time. The data represent the permeability changes in the
presence of PD098059 over changes by DMSO alone. They were
obtained in a representative experiment and are expressed as the mean
fold increase (± SEM) in treated cells relative to untreated cells (n=4 for
each conditions). p value was determined by using unpaired Student t
test. Figure S3. Hs_TPM1_7 small RNA interference-mediated knockdown
of human endogenous Tm1 is effective. A) HUVECs were transfected or
not (a-b) with siRNAs that specifically target human Tm1 mRNA (siRNA
#7; e-f) or with non-targeting negative control siRNA (c-d) along with
plasmid expressing pEGFP-C1. Thereafter, cells were fixed, were
permeabilized, and were stained for nuclei using DAPI, for GFP using
anti-GFP rabbit antibody, and for Tm1 using an anti-tropomyosin mouse
monoclonal antibody. A representative field for each condition was
captured using a Nikon Eclipse 600 fluorescence microscope (20X).
Arrowheads indicate GFP positive cells. B) Fifteen independent fields
from each condition were captured in A, and GFP positive cells were
counted. Cells containing a decrease in Tm1 expression were evaluated.
The percentage of Tm1 knocked down cells is shown. p value was
determined by using unpaired Student t test. Figure S4. Functionality of
lentiviral transgenic expressing vectors (CSII-Venus, CSII-Venus-Tm1wt,and CSII-Venus-Tm1S283A). A) Exponentially growing HUVECs were
transduced with CSII-Venus (empty vector; MOI of 30.8) or CSII-Venus-
Tm1wt (Tm1 wild-type vector; MOI of 10.4) or CSII-Venus-Tm1S283A
(non-phosphorylatable Tm1 mutant vector; MOI of 9.9) using lentivirus-
mediated infection. HUVECs were cultivated for 4 days until the
formation of a tight monolayer for each condition. Endothelial layers
were visualized at 20x magnification by phase contrast (a, d, and g) and
by fluorescence microscopy (b, e, and h). A representative field for each
condition was captured and a merged picture is shown for each
condition (c, f, and i). B) Four independent fields were captured from
each lentivirus-mediated infection condition and VENUS positive cells
were counted. The percentage of lentiviral-mediated infection from
HUVECs monolayer is shown. C) Exponentially growing HUVECs were
transduced with CSII-Venus (empty vector; MOI of 30.2) or CSII-Venus-
Tm1wt (Tm1 wild-type vector; MOI of 7.59) or CSII-Venus-Tm1S283A
(non-phosphorylatable Tm1 mutant vector; MOI of 6.66) using lentivirus-
mediated infection. After 24 hours, infected HUVECs were transfected or
not with Tm1 siRNA #7. Four days later, proteins were extracted from
cells, were separated by SDS-PAGE, and were transferred onto
nitrocellulose membrane. Tm1 level was revealed by western blotting
using anti-tropomyosin mouse monoclonal antibody (lower panel).
Tubulin-α level was measured as loading control (upper panel). D)
Relative Tm1 protein levels from C were quantified (Tm1/Tubulin) by
densitometry analysis using Image J software and is shown. The
experiments are performed at least in triplicates. Figure S5. Lentivirus-
mediated infection does not increase by itself endothelial permeability.
Exponentially growing HUVECs were transduced or not with CSII-Venus
(empty vector; MOI of 30.2) using lentivirus-mediated infection. After
24 hours, infected or non-infected HUVECs were transfected or not
(controls) with Tm1 siRNA #7. The next day, HUVECs were plated at a
density of 1×105 cells per well in the upper part of Boyden chambers
and were cultivated for 3 days until the formation of a tight monolayer.
Thereafter, NaF (1 mM for 1 hour) was added to the incubation medium
(upper chamber) to inhibit phosphatases and to allow the accumulation
of phosphorylated tropomyosin-1. Then, H2O2 (250 μM) was added for
30, 60, and 90 minutes to the upper chamber in the presence of 1 mg/
ml FITC-labelled dextran. Passage of FITC-labelled dextran through the
monolayer of HUVECs was measured immediately after exposure of
HUVECs to H2O2. The data represent permeability expressed as the mean
fold increases (± SEM) relative to untreated cells (n=4). p value was
determined by using unpaired Student t test. Figure S6. Lentivirus-
mediated infection does affect endothelial cell survival. Exponentially
growing HUVECs were transduced or not with CSII-Venus vectors (empty
vector; MOI of 30.8; CSII-Venus-Tm1 wild type vector, MOI of 10.4; CSII-
Venus-Tm1S283A mutant vector, MOI of 9.9) using lentivirus-mediated
infection. After 24 hours, infected or non-infected HUVECs were
cultivated to confluence in a 96-well plates. They were left untreated or
were treated for 30 min with 250 μM H2O2. Medium containing H2O2
was removed and fresh medium was added. Then, cells were processed
for WST-1 assay. Thereafter, absorbance of the samples was determined
at 420-480 nm to evaluate the mitochondrial dehydrogenase activity of
viable cells as measured by the formation of formazan dye from WST-1.
Results are expressed as the mean DO values (+/−SEM) of viable cells
from triplicate samples in each condition and are from a representative
experiment. p value was determined by using unpaired Student t test.Competing interests
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